Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival.
Mol Cell Endocrinol · 2012
Last updated 2026-05-28MIN6 cells naturally produce GLP-1, a hormone that helps regulate insulin and cell survival. When treated with exendin-4 (Ex4), a GLP-1 receptor agonist, the cells increased GLP-1 production and improved cell function and survival. Blocking GLP-1 with exendin-(9-39) (Ex9) or an anti-GLP-1 receptor antibody reduced cell survival.
AI summary of the abstract below.
| Journal | Mol Cell Endocrinol, 2012 |
|---|---|
| Citations | 9 |
| Relative citation ratio | 0.27 |
| NIH percentile | 17 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
Based on the hypothesis that MIN6 cells could produce glucagon-like peptide-1 (GLP-1) to maintain cell survival, we analyzed the effects of GLP-1 receptor agonist, exendin-4 (Ex4), and antagonist, exendin-(9-39) (Ex9) on cell function and cell differentiation. MIN6 cells expressed proglucagon mRNAs and produced GLP-1, which was accelerated by Ex4 and suppressed by Ex9. Moreover, Ex4 further enhanced glucose-stimulated GLP-1 secretion, suggesting autocrine loop-contributed amplification of the GLP-1 signal. Ex4 up-regulated cell differentiation- and cell function-related CREBBP, Pdx-1, Pax6, proglucagon, and PC1/3 gene expressions. The confocal laser scanning images revealed that GLP-1 positive cells were dominant in the early stage of cells, but positive for insulin were more prominent in the mature stage of cells. Ex4 accelerated cell viability, while Ex9 and anti-GLP-1 receptor antibody enhanced cell apoptosis. MIN6 cells possess a mechanism of GLP-1 signal amplification in an autocrine fashion, by which the cells maintained insulin production and cell survival.
Verbatim abstract via PubMed 22108438 ↗